Keywords: Parkinson's disease; 6-OHDA; Reserpine; Beta oscillations; Gamma oscillations; Cortico-basal ganglia loop;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 6-OHDA; 6-hydroxydopamine; ABTS; 2,2â²-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid); BSA; bovine serum albumin; CNS; central nervous system; CPu; caudate putamen; CXCL12; chemokine (C-X-C motif) ligand 12; CXCR4; chemokine (C-X-C motif) Rece
Keywords: 6-OHDA; 6-hydroxydopamine; ABC; ATP-binding cassette; ATP; adenosine triphosphate; BBB; blood-brain barrier; BCEC; brain capillary endothelial cell; bFGF; basic fibroblast growth factor; CHE; cholesteryl hexadecyl ether; CNS; central nervous system; CSF
Keywords: 3-NPA; 3-nitropropionic acid; 6-OHDA; 6-hydroxy dopamine; AD; Alzheimer's disease; AIF; apoptosis inducing factor; ALS; amyotrophic lateral sclerosis; APP; amyloid precursor protein; AÃ; β-amyloid peptide; CA; trans-cinnamaldehyde; Cat; catalase; CBP;
Keywords: 6-OHDA; 6-hydroxydopamine; ACE; angiotensin converting enzyme; ACEIs; ACE inhibitors; AII; angiotensin II; AT1; AII type 1 receptor; AT2; AII type 2 receptor; CNS; central nervous system; DA; dopamine; DPN; 2,3-Bis-4-hydroxyphenyl-propionitrile, ER-β ago
Keywords: Dopaminergic neurons; Sonic hedgehog; Smoothened; Parkinson's disease; 6-OHDA;
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; CSF; cerebrospinal fluid; DA; dopamine; DAB; diaminobenzidine; DARTEL; diffeomorphic anatomical registration using exponentiated lie algebra; FWER; family-wise error rate; GM; gray matter; GMV; gray
Keywords: 6-OHDA; 6-hydroxydopamine; ADTIQ; 1-acetyl-6, 7-dihydroxyl-1, 2, 3, 4-tetrahydroisoquinoline; AMPK; 5â²-AMP-activated protein kinase; ATF; activating transcription factor 6; ATM; ataxia telangiectasia mutated; CHOP; CCAAT/-enhancer-binding protein homolo
Keywords: 3-MA; 3-methyladenine; 6-OHDA; 6-hydroxydopamine; AD; Alzheimer's disease; AIF; apoptosis inducing factor; ALR; autophagosome-lysosome reformation; ALS; amyotrophic lateral sclerosis; AMD; age- dependent macular degeneration; ApoE; apolipoprotein E; APP
Keywords: ACC; Anterior Cingulate Cortex; BLA; Baso-Lateral Amygdala; DLS; Dorsolateral Striatum; DMS; Dorsomedial; IL; Infra-Limbic Cortex; lOFC; Lateral Orbitofrontal Cortex; MD; mediodorsal thalamus; mOFC; Medial Orbitofrontal Cortex; mPFC; medial prefrontal cor
Keywords: OS; oxidative stress; CNS; central nervous system; ROS; reactive oxygen species; SOD; superoxide dismutase; CAT; catalase; Cu; copper; Zn; zinc; Mn; manganese; Fe; iron; Ni; nickel; DA; dopamine; PHOX; NADPH oxidase; Nrf2; nuclear factor erythroid 2-relat
Keywords: 6MWT; six-minute walking test; 6-OHDA; 6-hydroxydopamine; 9HPT; 9-hole peg test; ACE; Addenbrooke's cognitive examination; ADLs; activities of daily life; AIMS; abnormal involuntary movement scale; ASI; anxiety status inventory; ASs; autonomic symptoms; B
Keywords: 6-OHDA; 6-hydroxydopamine; PD; Parkinson's disease; CPA; costophrenic angle; Respiration; Diaphragm; Radiography; Disease models; Behavior; Animal;
Keywords: 6-OHDA; 6-hydroxydopamine; [Ca2 +]o; extracellular calcium concentration; [DA]o; extracellular dopamine concentration; ACh; acetylcholine; ChI; cholinergic interneuron; CFM; carbon-fibre microelectrode; DA; dopamine; DAT; dopamine transporter; DHβE; dih
Keywords: Human adipose-derived stem cells; 6-OHDA; Parkinson's disease; Mitochondria;
Keywords: DA; dopamine; NE; norepinephrine; 6-OHDA; 6-hydroxydopamine; DMI; desipramine; PFC; prefrontal cortex; HPLC; high-performance liquid chromatography; Catecholamine; Medial prefrontal cortex; Body weight; Glucose preference;
Keywords: 5-HT; 5-hydroxytryptamine; 5-HT7; serotonin7; 6-OHDA; 6-hydroxydopamine; DA; dopamine; DMSO; dimethyl sulfoxide; FST; forced swim test; MFB; medial forebrain bundle; mPFC; medial prefrontal cortex; NA; noradrenaline; PD; Parkinson's disease; PrL; prelim
Keywords: DA; dopamine; PD; Parkinson's disease; ADHD; attention-deficit hyperactivity disorder; ASD; autism spectrum disorders; SRY; sex-determining region on the Y chromosome; SNc; substantia nigra pars compacta; SNr; substantia nigra pars reticulata; VTA; ventra
Keywords: 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; CV; coefficient of variation; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; EPM; elevated plus maze; HPLC; high performance liquid chromato
Keywords: 3-MT; 3-methoxytyramine; 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; DOPAC; 3,4-dihydroxyphenylacetic acid; HPLC; high-performance liquid chromatography; HVA; homovanillic acid; MFB; medial forebrain bundle; MPTP; 1-methyl-4-phenyl-1,2,3,6-tet
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BSA; bovine serum albumin; BT; beam test; CAT; catalase enzyme; CE; corticospinal pathway; CSB; circular small beam; CT; cylinder test; EA; enzyme activity; iNOS; inducible NO synthase; i.p.; intrape
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BDNF; brain-derived neurotrophic factor; DA; dopaminergic; DMEM; Dulbecco's modified Eagle's medium; E12; embryonic day 12; FCS; fetal calf serum; FGF-2; fibroblast growth factor 2; GDNF; glial c
Keywords: 5-HIAA; 5-hydroxyindolacetic acid; 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; AIMs; Abnormal involuntary movements; ARC; activity-regulated cytoskeletal-associated protein; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; EDTA; ethylenediaminetetraac
Keywords: Dendritic spine; Synaptic plasticity; Neurodegenerative diseases; Psychiatric disorders; Glutamate receptor; Calcium signaling; ADHD; attention deficit hypersensitive disorders; FXS; Fragile X-syndrome; CNS; central nervous system; GABA; gamma amino butyr
Keywords: AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; DMAEMA; 2-dimethylaminoethyl methacrylate; HD; Huntington's disease; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MS; multiple sclerosis; 6-OHDA; 6-hydroydopamin
Keywords: AAV; adeno-associated viral vectors; CPA; conditioned place aversion; CPP; conditioned place preference; DA; dopamine; DDS; dopamine dysregulation syndrome; DRT; dopamine replacement therapy; ICB; impulsive-compulsive behavior; ICSS; intracranial self-s
Keywords: 6-OHDA; Neuroprotection; Neurorescue; Disease-modifying;
Keywords: 6-OHDA; Environmental enrichment; Exercise; MPTP; Mice; Neuroprotection; Neurotrophic factors; Rats
Keywords: 6-OHDA; 6-hydroxydopamine; APO; apomorphine; H & Y; Hoehn and Yahr; MLT; melatonin; PD; Parkinson's disease; SEM; standard error of mean.; Parkinson's disease; Serum melatonin; Hoehn and Yahr scale; 6-Hydroxydopamin;
Keywords: 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; BDNF; brain-derived neurotrophic factor; DA; dopamine; EDTA; ethylenediaminetetraacetic acid; FST; forced swimming test; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; OFT; open-field test; p75NTR; pan-neur
Keywords: Parkinson's disease; 6-Hydroxydopamine; The subthalamic nucleus; High frequency stimulation; Dopamine; 6-OHDA; 6-hydroxydopamine; DBS; deep brain stimulation; DOPAC; dihydroxyphenylacetic acid; FCV; fast cyclic voltammetry; HPLC; high-performance liquid c
Keywords: Neuroinflammation; Neurotoxin; Nigrostriatal; Neurodegeneration; Dopaminergic; Microglia; 6-OHDA; MPTP; LPS; Paraquat; Parkinson's disease
Keywords: Centromedian-parafascicular; complex; Entopeduncular nucleus; Levodopa-induced dyskinesias; 6-OHDA;
Keywords: 6-OHDA; 6-hydroxyldopamine; D1R; dopamine D1 receptor; D2R; dopamine D2 receptor; DCX; doublecortin; DG; dentate gyrus; HD; Huntington's disease; L-DOPA; 3,4-dihydroxy-l-phenylalanine; micro-PET; micro-positron emission tomography; MFB; medial forebrain b
Keywords: 6-OHDA; 6-hydroxydopamine; BDNF; brain-derived neurotrophic factor; CNS; central nervous system; DMT1Â +Â IRE; divalent metal transporter 1 with iron responsive element; ERK1/2; extracellular-regulated kinase1/2; GDNF; glial cell line-derived neurotrophic
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; BW; body weight; CAT; catalase; CS; citrate synthase; DA; dopamine; DAT; dopamine transporter; DCHF-DA; 2â²,7â²-dichlorofluorescein diacetate; DCF; 2â²,7â²-dichlorofluorescein; DOPAC; 3,4-dihydro
Keywords: 6-OHDA; 6-hydroxydopamine; CB; calbindin; CNS; central nervous system; CR; calretinin; DA; dopamine; DAB; 3,3â²-Diaminobenzidine; GABA; γ-amino-butyric acid; Gad67; glutamic acid decarboxylase 67; GFAP; glial fibrillary acidic protein; MPTP; 1-methyl-4-
Keywords: ACh; acetylcholine; AAV; adeno-associated virus; AgRP; agouti-related protein; ArchT; archaerhodopsin; BAC; bacterial artificial chromosomes; ChRs; channelrhodopsins; DBS; deep brain stimulation; DREADDs; designer receptors exclusively activated by design
Keywords: 6-OHDA; 6-hydroxydopamine; AMPK; AMP activated protein kinase; cAMP; cyclic adenosine monophosphate; CAT; catalase; CI; complex I; CII; complex II; CIV; complex IV; COX; cytochrome c oxidase; DMSO; dimethyl sulfoxide; DNP; dinitrophenol; DCF; dichlorodihy
Keywords: Essential tremor; Brain; Genetics; Human population; Mouse models; Pathophysiology; ABA; Allen brain atlas; AβPPswe/PS1ÎE9; amyloid-β protein precursor and presenilin-1; AD; Alzheimer's disease; ALS; amyotrophic lateral sclerosis; ATP; adenosine tri-ph
Keywords: Antioxidant gene therapy; Brain ischemia; Neurodegenerative disorders; Oxidative stress; Virus-mediated gene delivery; ROS; ÎΨm; mitochondrial membrane potential; 3-NP; 3-nitropropionic acid; 6-OHDA; 6-hydroxydopamine; AADC; aromatic-l-amino decarboxyla
Keywords: Ach; acetylcholine; AchE; acetylcholine esterease; ACTH; adrenocorticotrophic hormone; ADHD; attention deficit/hyperactivity disorder; AIDS; autoimmune deficiency syndrome; AMSH; alpha-melanocyte-stimulating hormone; BAM; bovine adrenal medulla peptide; B
Keywords: Parkinson's disease; Pain; 6-OHDA; Electronic von Frey test; Animal model;
Keywords: AD; Alzheimer's disease; CSF; cerebrospinal fluid; HDC; histidine decarboxylase; HRs; histamine receptors; HMT; histamine-methyltransferase; 6-OHDA; 6-hydroxydopamine; LBs; Lewy bodies; LNs; Lewy neuritis; MT; melatonin receptor; PD; Parkinson's disease;
Keywords: Neuronal cell death; Neurons; 6-OHDA; Antioxidant; ROS;
Keywords: Neuroprotection; Forced exercise; Voluntary exercise; Parkinson's disease; Exercise; 6-OHDA;
Keywords: 6-OHDA; 6-hydroxydopamine; GP; globus pallidus; HPLC; high-performance liquid chromatography; PD; Parkinson's disease; SNc; pars compacta of substantia nigra; SNr; pars reticulata of substantia nigra; STN; subthalamic nucleus; Parkinson's disease; dop
Keywords: 6-OHDA; 6-hydroxydopamine; ANOVA; analysis of variance; D1 receptor; dopamine type 1 receptor; D2 receptor; dopamine type 2 receptor; GAD67; glutamic acid decarboxylase 67; mRNA; messenger RNA; PD; Parkinson's disease; RNase; ribonuclease; SSC; saline-sod
Keywords: 6-OHDA; 6-hydroxydopamine; AA; Arachidonic; AD; Alzheimer's disease; ALA; α-linolenic acid; ApoE4; Apolipoprotein E4 allele; APP; Amyloid precursor protein; ATP; Adenosine triphosphate; Aβ; Beta-amyloid peptide; CAG; Cytosine-adenine-guanine; DHA;
Keywords: Crystalline lens; Color vision; Lens aberrations; Refractive index gradient; Lens fiber cell; Visual evolution; BCD; Back center distance; BEP; Beam entrance position; DA; Dopamine; 6-OHDA; 6-hydroxy-dopamine; IOS; Inner/outer segment; LSA; Longitudinal s